Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manabu Morimoto

Showing results (31-40 of 160) with videos related to

Pageof 16
Sort By:
European Journal of Radiology|April 14, 2009
Role of Sonazoid-enhanced three-dimensional ultrasonography in the evaluation of percutaneous radiofrequency ablation of hepatocellular carcinomaWen Luo, Kazushi Numata, Manabu Morimoto, et al.
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|March 27, 2009
Sonazoid-enhanced ultrasonography for evaluation of the enhancement patterns of focal liver tumors in the late phase by intermittent imaging with a high mechanical indexWen Luo, Kazushi Numata, Masaaki Kondo, et al.
BMC Cancer|May 20, 2021
Association between time to stent dysfunction and the anti-tumour effect of systemic chemotherapy following stent placement in patients with pancreaticobiliary cancers and malignant gastric outlet obstruction: a retrospective cohort studySatoshi Kobayashi, Makoto Ueno, Shuhei Nagashima, et al.
Journal of Medical Ultrasonics (2001)|June 10, 2016
Use of accumulation images obtained by arterial-phase contrast-enhanced harmonic grayscale ultrasonography to evaluate tumor vessels in focal nodular hyperplasia and other hepatic tumorsKazushi Numata, Manabu Morimoto, Tetsuo Isozaki, et al.
European Journal of Radiology|December 18, 2009
Evaluation of the therapeutic efficacy of high-intensity focused ultrasound ablation of hepatocellular carcinoma by three-dimensional sonography with a perflubutane-based contrast agentKazushi Numata, Hiroyuki Fukuda, Masao Ohto, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 6, 2002
[A case of AFP-producing gastric cancer with multiple liver metastases responding to CPT-11 and cisplatin combination chemotherapy]Takeshi Asami, Atsushi Kokawa, Kazuya Sugimori, et al.
European Journal of Gastroenterology & Hepatology|February 1, 2022
Impact of psoas muscle index assessed by a simple measurement method on tolerability and duration of continued treatment with sorafenib in hepatocellular carcinoma patientsKatsuaki Ogushi, Makoto Chuma, Kazushi Numata, et al.
Cancer Chemotherapy and Pharmacology|October 27, 2017
Phase II study of fixed dose-rate gemcitabine plus S-1 as a second-line treatment for advanced biliary tract cancerSatoshi Kobayashi, Makoto Ueno, Kazuya Sugimori, et al.
Nutrition and Cancer|January 13, 2021
Randomized Phase II Study of Gemcitabine Monotherapy vs. Gemcitabine with an EPA-Enriched Oral Supplement in Advanced Pancreatic CancerMakoto Ueno, Kazuya Sugimori, Masataka Taguri, et al.
Anticancer Research|March 14, 2013
Fucosylated fraction of alpha-fetoprotein as a serological marker of early hepatocellular carcinomaSatoshi Moriya, Manabu Morimoto, Kazushi Numata, et al.
Pageof 16

Showing results (31-40 of 160) with videos related to

Sort By:
Pageof 16
European Journal of Radiology|April 14, 2009
Role of Sonazoid-enhanced three-dimensional ultrasonography in the evaluation of percutaneous radiofrequency ablation of hepatocellular carcinomaWen Luo, Kazushi Numata, Manabu Morimoto, et al.
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|March 27, 2009
Sonazoid-enhanced ultrasonography for evaluation of the enhancement patterns of focal liver tumors in the late phase by intermittent imaging with a high mechanical indexWen Luo, Kazushi Numata, Masaaki Kondo, et al.
BMC Cancer|May 20, 2021
Association between time to stent dysfunction and the anti-tumour effect of systemic chemotherapy following stent placement in patients with pancreaticobiliary cancers and malignant gastric outlet obstruction: a retrospective cohort studySatoshi Kobayashi, Makoto Ueno, Shuhei Nagashima, et al.
Journal of Medical Ultrasonics (2001)|June 10, 2016
Use of accumulation images obtained by arterial-phase contrast-enhanced harmonic grayscale ultrasonography to evaluate tumor vessels in focal nodular hyperplasia and other hepatic tumorsKazushi Numata, Manabu Morimoto, Tetsuo Isozaki, et al.
European Journal of Radiology|December 18, 2009
Evaluation of the therapeutic efficacy of high-intensity focused ultrasound ablation of hepatocellular carcinoma by three-dimensional sonography with a perflubutane-based contrast agentKazushi Numata, Hiroyuki Fukuda, Masao Ohto, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 6, 2002
[A case of AFP-producing gastric cancer with multiple liver metastases responding to CPT-11 and cisplatin combination chemotherapy]Takeshi Asami, Atsushi Kokawa, Kazuya Sugimori, et al.
European Journal of Gastroenterology & Hepatology|February 1, 2022
Impact of psoas muscle index assessed by a simple measurement method on tolerability and duration of continued treatment with sorafenib in hepatocellular carcinoma patientsKatsuaki Ogushi, Makoto Chuma, Kazushi Numata, et al.
Cancer Chemotherapy and Pharmacology|October 27, 2017
Phase II study of fixed dose-rate gemcitabine plus S-1 as a second-line treatment for advanced biliary tract cancerSatoshi Kobayashi, Makoto Ueno, Kazuya Sugimori, et al.
Nutrition and Cancer|January 13, 2021
Randomized Phase II Study of Gemcitabine Monotherapy vs. Gemcitabine with an EPA-Enriched Oral Supplement in Advanced Pancreatic CancerMakoto Ueno, Kazuya Sugimori, Masataka Taguri, et al.
Anticancer Research|March 14, 2013
Fucosylated fraction of alpha-fetoprotein as a serological marker of early hepatocellular carcinomaSatoshi Moriya, Manabu Morimoto, Kazushi Numata, et al.
Pageof 16